Platform

Home
Studies

Other

Terms of Service
Privacy Policy

Studies

Overview

Key facts that identify this study and show where it stands today.

Description

What the study is about and why it is being run, in the researchers' own words.

Conditions

The medical conditions and diseases this study investigates.

Interventions

The treatments and procedures being evaluated in this study.

Participation

Who can join this study and the criteria used to decide.

Design

How the study is designed and how its participant groups are organized.

Contacts

The people to reach with questions about this study or how to join it.

Locations

Where the study is run and whether each site is currently recruiting.

Collaborators

The organizations and people involved in this study.

Similar Studies

Other registered studies that closely resemble this one.

On this page

Overview
Description
Conditions
Interventions
Participation
Design
Contacts
Locations
Collaborators
Similar Studies

Workspace

Terms of Service

NCT00636766

Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
NCT02114697
TerminatedInterventionalPhase 4Updated Sep 11, 2018
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NCT05624658
Unknown statusInterventionalNot ApplicableUpdated Nov 18, 2023
The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques
NCT01773512
Unknown statusInterventionalPhase 4Updated Jan 23, 2013
Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic Plaques
NCT00449306
Unknown statusObservationalUpdated Jul 5, 2019
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
NCT00307307
CompletedInterventionalPhase 4Updated May 22, 2006
Evaluation of Atorvastatin on Atherosclerosis Composition
NCT00576576
CompletedInterventionalNot ApplicableUpdated Dec 24, 2013

Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque | NCT00636766 | Trialant

CompletedInterventionalNot ApplicableUpdated Nov 2, 2012

Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque

Atherosclerotic Plaque Texture-Experimental and Clinical Study on the Diagnostic and Therapeutic Strategies of Atherosclerotic Plaque Vulnerability

ClinicalTrials.gov ID: NCT00636766
Lead Sponsor: Aristotle University Of ThessalonikiOTHER
Overall Status: Completed
Study Type: Interventional
Phase: Not Applicable
Enrollment: 300Actual
Last Update Posted: Nov 2, 2012Estimated
Start Date: Sep 2005
Primary Completion Date: Dec 2007Actual
Completion Date: Jan 2009Actual

Official Title: Atherosclerotic Plaque Texture-Experimental and Clinical Study on the Diagnostic and Therapeutic Strategies of Atherosclerotic Plaque Vulnerability
Brief Summary: The aim of the present study is to examine the atherosclerotic plaque stability using in vivo and in vitro techniques and to investigate the influence of exercise, anti-diabetic, lipid-lowering and cannabinoids receptor antagonists on atherosclerotic plaque texture in patients with cardiovascular risk and animals prone to atherosclerosis.

Carotid Atherosclerosis
Stroke
Type 2 Diabetes
Metabolic Syndrome

atorvastatin
rimonabant
rosiglitazone
metformin

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Eligibility Criteria: Inclusion Criteria:

Carotid atherosclerosis

Femoral atherosclerosis

Cardiovascular risk

Exclusion Criteria:

Heart failure

Renal disease

Liver disease

Life-threatening diseases

Allocation: Randomized
Interventional Model: Factorial Assignment
Masking: None (Open Label)

No central contacts

There are no central contacts for this study.

General Hospital of Thessaloniki "Hippokratio"

Thessaloniki, Greece

Lead Sponsor: Aristotle University Of ThessalonikiOTHER